• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤。

Osteosarcoma.

机构信息

Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.

Radiotherapy and Radiooncology, Outpatient Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28352. doi: 10.1002/pbc.28352. Epub 2020 Aug 11.

DOI:10.1002/pbc.28352
PMID:32779875
Abstract

Osteosarcoma is a rare tumor that requires complex multidisciplinary management. This paper reviews the general management and standard radiotherapy guidelines for osteosarcoma in both North America and Europe in a joined effort between the Children's Oncology Group and International Society of Pediatric Oncology. Standard treatment involves multiagent induction chemotherapy followed by surgical resection for local tumor control and consolidation local control to metastatic sites. Radiotherapy is reserved for cases with a marginal or incomplete resection or for definitive treatment in the case of unresectable disease. We present supporting data for the role of chemotherapy, surgery, and radiation therapy.

摘要

骨肉瘤是一种罕见的肿瘤,需要复杂的多学科管理。本文由北美儿童肿瘤协作组和国际儿童肿瘤学会合作,回顾了北美和欧洲骨肉瘤的一般管理和标准放疗指南。标准治疗包括多药诱导化疗,然后进行手术切除以控制局部肿瘤,并对转移部位进行局部巩固治疗。放疗保留用于边缘或不完全切除的病例,或用于不可切除疾病的确定性治疗。我们提供了支持化疗、手术和放疗作用的数据。

相似文献

1
Osteosarcoma.骨肉瘤。
Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28352. doi: 10.1002/pbc.28352. Epub 2020 Aug 11.
2
Ewing sarcoma.尤因肉瘤。
Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28355. doi: 10.1002/pbc.28355.
3
Local treatment of Ewing's sarcoma: radiation therapy versus surgery.尤因肉瘤的局部治疗:放射治疗与手术治疗对比
Cancer Treat Rep. 1984 May;68(5):695-701.
4
Role of radiation therapy for pediatric upper extremity extraskeletal osteosarcoma: A case series.儿童上肢骨外骨肉瘤放疗作用:病例系列。
Pediatr Blood Cancer. 2020 Feb;67(2):e28018. doi: 10.1002/pbc.28018. Epub 2019 Nov 11.
5
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.非随机治疗试验,以确定不可切除骨肉瘤患者重离子放疗的安全性和有效性。
BMC Cancer. 2010 Mar 12;10:96. doi: 10.1186/1471-2407-10-96.
6
The role of radiation treatment in the contemporary management of bone tumors.放射治疗在当代骨肿瘤治疗中的作用。
J Natl Compr Canc Netw. 2007 Apr;5(4):456-66. doi: 10.6004/jnccn.2007.0040.
7
Radiotherapy for local control of osteosarcoma.用于骨肉瘤局部控制的放射治疗。
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):492-8. doi: 10.1016/j.ijrobp.2004.05.051.
8
Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities.肢体高级别骨肉瘤的新辅助化疗和局部放疗
Mayo Clin Proc. 2003 Feb;78(2):147-55. doi: 10.4065/78.2.147.
9
[Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004].[骨肉瘤患者治疗中放射治疗使用的标准与选择。2004年更新]
Cancer Radiother. 2005 Mar;9(2):104-21. doi: 10.1016/j.canrad.2005.01.007.
10
The role of radiotherapy in oseosarcoma.放射疗法在骨肉瘤中的作用。
Cancer Treat Res. 2009;152:147-64. doi: 10.1007/978-1-4419-0284-9_7.

引用本文的文献

1
Molecular Crosstalk Between RUNX2 and HIF-1α in Osteosarcoma: Implications for Angiogenesis, Metastasis, and Therapy Resistance.骨肉瘤中RUNX2与HIF-1α之间的分子串扰:对血管生成、转移和治疗抗性的影响
Int J Mol Sci. 2025 Aug 7;26(15):7642. doi: 10.3390/ijms26157642.
2
Surgical Margin Analysis in Osteosarcoma: Impact on Survival and Local Control.骨肉瘤手术切缘分析:对生存及局部控制的影响
Cancers (Basel). 2025 Aug 6;17(15):2581. doi: 10.3390/cancers17152581.
3
Extensive thoracic vertebral and chest wall metastases as the initial presentation of breast cancer: a case report and literature review.
广泛胸椎及胸壁转移作为乳腺癌的首发表现:一例病例报告及文献复习
Front Oncol. 2025 Jul 17;15:1632700. doi: 10.3389/fonc.2025.1632700. eCollection 2025.
4
Yin Yang 1 protein-activated N-acetyltransferase 10 drives cell malignant progression of osteosarcoma through ac4C acetylation of integrin β3.阴阳1蛋白激活的N-乙酰转移酶10通过整合素β3的ac4C乙酰化驱动骨肉瘤细胞的恶性进展。
J Bone Oncol. 2025 Jul 12;53:100701. doi: 10.1016/j.jbo.2025.100701. eCollection 2025 Aug.
5
Recent advances in hydrogel-assisted treatment of malignant bone tumors.水凝胶辅助治疗恶性骨肿瘤的最新进展
Mater Today Bio. 2025 Jul 14;33:102088. doi: 10.1016/j.mtbio.2025.102088. eCollection 2025 Aug.
6
Transcription factor CREB1 promotes malignant growth of osteosarcoma cells by inhibiting miRNA-183-5p and regulating PROX1 expression.转录因子CREB1通过抑制miRNA-183-5p并调节PROX1表达来促进骨肉瘤细胞的恶性生长。
Mol Biol Rep. 2025 Jun 28;52(1):647. doi: 10.1007/s11033-025-10741-7.
7
Circular RNA rising star: new findings of circPRMT5 in cancer.环状RNA后起之秀:circPRMT5在癌症中的新发现
Mol Biol Rep. 2025 Jun 18;52(1):613. doi: 10.1007/s11033-025-10638-5.
8
Recent Research on the Role of Phytochemicals from Ginseng in Management of Osteosarcoma, Osteoporosis, and Osteoarthritis.人参中植物化学物质在骨肉瘤、骨质疏松症和骨关节炎治疗中作用的最新研究
Nutrients. 2025 Jun 1;17(11):1910. doi: 10.3390/nu17111910.
9
Integrating Radiogenomics and Machine Learning in Musculoskeletal Oncology Care.将放射基因组学与机器学习整合于肌肉骨骼肿瘤护理中。
Diagnostics (Basel). 2025 May 29;15(11):1377. doi: 10.3390/diagnostics15111377.
10
Enhancing radiosensitivity of osteosarcoma by ITGB3 knockdown: a mechanism linked to enhanced osteogenic differentiation status through JNK/c-JUN/RUNX2 pathway activation.通过敲低整合素β3(ITGB3)增强骨肉瘤的放射敏感性:一种通过JNK/c-JUN/RUNX2途径激活与增强成骨分化状态相关的机制。
J Exp Clin Cancer Res. 2025 May 24;44(1):159. doi: 10.1186/s13046-025-03417-4.